Navigation Links
Kendle Experts to Share Insights at the Regulatory Affairs Professionals Society Annual Conference and Exhibition
Date:9/11/2009

CINCINNATI, Sept. 11 /PRNewswire-FirstCall/ -- Kendle (Nasdaq: KNDL), a leading, global full-service clinical research organization, today announced that its regulatory affairs experts will share their insights on key industry topics at the Regulatory Affairs Professionals Society (RAPS) Annual Conference and Exhibition to be held Sept. 13-16 at the Pennsylvania Convention Center in Philadelphia. Demonstrating its leadership position in providing regulatory guidance to its global pharmaceutical customers across the Phase I through IV clinical development process, Kendle has been selected to lead five sessions at the conference.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080923/CLTU095LOGO)

Kendle's presentations include:

"New Pregnancy and Lactation Labeling Rule Revisions"

Monday, Sept. 14, 11 a.m.-Noon

Lisa Jenkins, PhD, Group Leader, Regulatory Consulting and Submissions

"Drug/Biologic Preapproval Inspection (PAI) - A Survival Guide"

Monday, Sept. 14, 1:30-3 p.m.

Hari Nagaradona, PhD, Associate Director, Regulatory Consulting and Submissions

"Adaptive Clinical Trial Designs That Get Results"

Monday, Sept. 14, 1:30-3 p.m.

Lisa Jenkins, PhD, Group Leader, Regulatory Consulting and Submissions

"The Expanding Role of Regulatory Advice: Guidance meets Business Development Professional " - Panel Discussion

Monday, Sept. 14, 1:30-3 p.m.

William Sietsema, PhD, Vice President, U.S. Regulatory Consulting and Submissions

"Ethical Standards in Clinical Research"

Tuesday, Sept. 15, 3:30-5 p.m.

William Sietsema, PhD, Vice President, U.S. Regulatory Consulting and Submissions

Kendle at Booth #706

Kendle experts will be available for on-site meetings and to discuss the Company's full suite of regulatory affairs capabilities at booth #706 in the exhibition hall.

Kendle offers extensive regulatory affairs experience, including delivery of all types of projects from global submissions to specialist consulting services. The Company provides expertise and advice at every stage of the drug development process, from early development to market and beyond. Kendle can ensure a product's development is conducted efficiently and in a timely manner, ensuring its smooth transition into the marketplace. The Company's Regulatory Affairs experts understand the commercial imperatives underlining decisions such as where to submit first, or which regulatory route to follow in a particular region, and work with biopharmaceutical companies worldwide to design an appropriate strategy for any product anywhere in the world.

Kendle offers customers global regulatory centers of expertise around the world to meet their needs. These integrated locations include Rockville, Maryland and Cincinnati, Ohio in the United States; Ely, England and Edinburgh, Scotland in Europe; Sydney and Melbourne, Australia in the Asia/Pacific region; and Mexico City, Mexico in Latin America.

About Kendle

Kendle International Inc. (Nasdaq: KNDL) is a leading global clinical research organization providing the full range of early- to late-stage clinical development services for the world's biopharmaceutical industry. Our focus is on innovative solutions that reduce cycle times for our customers and accelerate the delivery of life-enhancing drugs to market for the benefit of patients worldwide. As one of the world's largest global providers of Phase I-IV services, we offer experience spanning more than 100 countries, along with industry-leading patient access and retention capabilities and broad therapeutic expertise, to meet our customers' clinical development challenges.

Additional information and investor kits are available upon request from Kendle, 441 Vine Street, Suite 500, Cincinnati, OH 45202 or from the Company's Web site at www.kendle.com.


'/>"/>
SOURCE Kendle International Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Kendle Experts to Present at the Drug Information Association 44th Annual Meeting
2. H3N2 Influenza Unlikely to Spread Between Humans, K-State Infectious Disease and Diagnostics Experts Say; Swine Exhibits at Fairs are Safe With Proper Hygiene
3. Leading Experts Endorse Biohearts Muscle Stem Cell MyoCell Therapy
4. SUNY Youth Sports Institute Convenes Top Experts in NYC Next Week to Present Research & Analysis on Energy Drink Health Impacts
5. Diabetes Experts Issue New Recommendations for Inpatient Glycemic Control - Call for Systemic Changes in Hospitals Nationwide
6. Quality Colonoscopy Exam Remains Best Strategy for Detection of Polyps and Cancers According to Experts From the American College of Gastroenterology
7. Experts Assert That Varian Technologies Deliver Speed and Clinical Accuracy in Treating Cancer Patients
8. Despite Advances in the Accuracy of CT Colonography in Detecting Polyps, Digestive Health Experts Urge Patients to Consider Risks and Realities
9. Cytels Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
10. Promise of Vicals CMV Vaccine Noted by Independent Experts
11. Heart Patients More Likely to Adopt Healthy Habits in 3-Year Program Led by Cardiac Rehabilitation Experts, Mayo Clinic Research Shows
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... , Oct. 12, 2017   Divoti USA ... Jewelry up to the standard of the latest FDA requirements, which ... 2017). Anyone in need of Medical ID jewelry such ... Alert Jewelry are engraved in terms of the new ... Divoti offers ...
(Date:10/11/2017)... 2017  True Health, a leader in integrated ... during National Breast Cancer Awareness month to educate ... Research recently published ... more than 10 million American women are at ... or BRCA2 and have not had testing. These mutations ...
(Date:10/7/2017)... IRVING, Texas , Oct. 6, 2017   ... industry with more than $100 billion in purchasing power, ... industry news and information. The Newsroom is ... chain and industry trends, infographics, expert bios, news releases, ... Besides having access to a wealth of resources at ...
Breaking Medicine Technology:
(Date:10/12/2017)... ... October 12, 2017 , ... IsoComforter, Inc. ( ... today the introduction of an innovative new design of the shoulder pad. The ... get maximum comfort while controlling your pain while using cold therapy. By utilizing ice ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... delivery system that we intend to develop to enable prevention of a major ... to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss is ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations ... literacy software tool, and the Cancer Patient Education Network (CPEN), an independent professional ... announce a new strategic alliance. , As CPEN’s strategic partner, HLI will ...
(Date:10/12/2017)... ... October 12, 2017 , ... Farm Forward joins ... other leading institutions in announcing the launch of the Leadership Circle , ... animals are raised for food. , Founding members of the Leadership Circle also ...
Breaking Medicine News(10 mins):